GB201904341D0 - Therapeutic methods - Google Patents

Therapeutic methods

Info

Publication number
GB201904341D0
GB201904341D0 GBGB1904341.3A GB201904341A GB201904341D0 GB 201904341 D0 GB201904341 D0 GB 201904341D0 GB 201904341 A GB201904341 A GB 201904341A GB 201904341 D0 GB201904341 D0 GB 201904341D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic methods
therapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1904341.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Discovery Ltd
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Priority to GBGB1904341.3A priority Critical patent/GB201904341D0/en
Publication of GB201904341D0 publication Critical patent/GB201904341D0/en
Priority to SG11202105911PA priority patent/SG11202105911PA/en
Priority to EP19821175.7A priority patent/EP3890737B1/en
Priority to KR1020217019978A priority patent/KR20210100127A/en
Priority to PCT/GB2019/053456 priority patent/WO2020115500A1/en
Priority to MX2021006542A priority patent/MX2021006542A/en
Priority to JP2021532119A priority patent/JP2022510700A/en
Priority to US17/299,971 priority patent/US20220016115A1/en
Priority to CA3121422A priority patent/CA3121422A1/en
Priority to AU2019393161A priority patent/AU2019393161A1/en
Priority to CN201980091404.7A priority patent/CN113395965A/en
Priority to BR112021010645-6A priority patent/BR112021010645A2/en
Priority to IL283687A priority patent/IL283687A/en
Ceased legal-status Critical Current

Links

GBGB1904341.3A 2018-12-06 2019-03-28 Therapeutic methods Ceased GB201904341D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1904341.3A GB201904341D0 (en) 2019-03-28 2019-03-28 Therapeutic methods
BR112021010645-6A BR112021010645A2 (en) 2018-12-06 2019-12-06 compound, 1-(((s)-7-((r)-3-cyclohexyl-2-methylpropanoyl)-10-hydroxy-7-azaspiro[4.5]decan-10-yl)methyl)-4-phenyl-5 -(piperazine-1-carbonyl)pyridin-2(1h)-one, pharmaceutical composition, methods for treating obesity, insulin resistance, type II diabetes, muscle atrophy, cancer and to reduce muscle wasting, and, usp19 inhibitor
JP2021532119A JP2022510700A (en) 2018-12-06 2019-12-06 USP19 inhibitor used in treatment
EP19821175.7A EP3890737B1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in a method of treating obesity, insulin resistance and type ii diabetes
KR1020217019978A KR20210100127A (en) 2018-12-06 2019-12-06 therapeutic USP19 inhibitors
PCT/GB2019/053456 WO2020115500A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
MX2021006542A MX2021006542A (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy.
SG11202105911PA SG11202105911PA (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
US17/299,971 US20220016115A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
CA3121422A CA3121422A1 (en) 2018-12-06 2019-12-06 Usp19 inhibitors for use in therapy
AU2019393161A AU2019393161A1 (en) 2018-12-06 2019-12-06 USP19 inhibitors for use in therapy
CN201980091404.7A CN113395965A (en) 2018-12-06 2019-12-06 USP19 inhibitors for treatment
IL283687A IL283687A (en) 2018-12-06 2021-06-03 Usp19 inhibitors for use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1904341.3A GB201904341D0 (en) 2019-03-28 2019-03-28 Therapeutic methods

Publications (1)

Publication Number Publication Date
GB201904341D0 true GB201904341D0 (en) 2019-05-15

Family

ID=66442813

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1904341.3A Ceased GB201904341D0 (en) 2018-12-06 2019-03-28 Therapeutic methods

Country Status (1)

Country Link
GB (1) GB201904341D0 (en)

Similar Documents

Publication Publication Date Title
IL282794A (en) Therapeutic methods
GB201804255D0 (en) Macrophage-based therapy
IL292502A (en) Therapeutic methods using vadadustat
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
IL288237A (en) Combination therapy
GB201912191D0 (en) New therapy
GB201918752D0 (en) New therapy
GB201906864D0 (en) Combination therapy
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201907647D0 (en) Therapeutic methods
GB201904341D0 (en) Therapeutic methods
GB201819936D0 (en) Therapeutic methods
GB201919036D0 (en) Therapy
GB201916983D0 (en) Therapy
GB201914848D0 (en) Therapy
GB201913797D0 (en) Therapy
GB201913785D0 (en) Therapy
GB201912524D0 (en) Therapy
GB201911948D0 (en) Therapy
GB201905592D0 (en) Therapeutic method
GB201905591D0 (en) Therapeutic method
GB201911064D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)